Bybit launched the Master Trading Challenge: TradFi VS Crypto, inviting traders across TradFi and crypto to compete on Bybit Copy Trading, with 300,000 USDT in prizes. The competition runs in two two-week rounds (Feb 9–24 and Feb 27–Mar 14, 2026), each with a 150,000 USDT prize pool and a leaderboard, and participants may choose between classic crypto perpetual contracts or TradFi-style products, with rankings based on team trading volume and profit and loss. Masters must have at least 20 unique active Followers, and the top 50 Masters in each round win prizes, including 39,000 USDT for first place; rewards cascade down to 31st through 50th, with half the team rewards distributed to Masters and the remaining half to Followers by proportional trading volume.
Separately, WAT Medical reports in JAMA Surgery that the EmeTerm wristband—utilizing transcutaneous acupoint electrical stimulation—significantly improves 2-hour PONV remission compared with metoclopramide, and reduces 24-hour relapse, with a favorable safety profile. The multicenter trial enrolled 232 female patients who developed moderate to severe PONV after thyroidectomy or anterior cervical surgery under general anesthesia. Participants were randomized 1:1 to active TEAS via the EmeTerm wristband versus a sham device combined with intravenous metoclopramide. The results showed a 2-hour remission rate of 77.6% with EmeTerm vs 55.2% with metoclopramide (P < 0.001), and a 24-hour relapse rate of 12.2% versus 56.3% (P < 0.001), with no device-related serious adverse events.
Leave a Reply